Jin et al. 15 reported that suppressing NT5DC2 inhibits the metastatic progression of non-small cell lung carcinoma (NSCLC) by regulating the p53 signaling pathway. The gene discussed is NT5DC2; the disease is non-small cell lung carcinoma.